SAN DIEGO, Nov. 13, 2018 /PRNewswire/ -- Shareholder rights
law firm Johnson Fistel, LLP has launched an investigation into
whether the board members of athenahealth, Inc. (NASDAQ: ATHN)
("athenahealth") breached their fiduciary duties in connection with
the proposed sale of the Company to Veritas Capital ("Veritas") and
Evergreen Coast Capital ("Evergreen").
On November 12, 2018, athenahealth
announced that it had signed a definitive merger agreement with
Veritas and Evergreen. Under the terms of the agreement,
athenahealth shareholders will receive $135 in cash per share.
The investigation concerns whether the athenahealth board failed
to satisfy its duties to the Company shareholders, including
whether the board adequately pursued alternatives to the
acquisition and whether the board obtained the best price possible
for athenahealth shares of common stock. Nationally recognized
Johnson Fistel is investigating
whether the proposed deal represents adequate consideration,
especially given that one Wall Street analyst has a $180.00 price target on the stock. The 52-week
high for athenahealth was $163.94.
If you are a shareholder of athenahealth and believe
the proposed buyout price is too low or you're interested in
learning more about the investigation or your legal rights and
remedies, please contact lead analyst Jim
Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing,
please include a phone number.
Additionally, you can [click here to join this
action].There is no cost or obligation to you.
About Johnson Fistel,
LLP:
Johnson Fistel, LLP is a nationally
recognized shareholder rights law firm with offices in California, New
York, and Georgia. The firm
represents individual and institutional investors in shareholder
derivative and securities class action lawsuits. For more
information about the firm and its attorneys, please visit
https://www.johnsonfistel.com. Attorney advertising. Past results
do not guarantee future outcomes.
Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com
[click here to join this action]
View original
content:http://www.prnewswire.com/news-releases/athenahealth-athn-alert-johnson-fistel-investigates-proposed-sale-of-athenahealth-inc-is-135-a-fair-price-300749143.html
SOURCE Johnson Fistel, LLP